Eric Mas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Eric Mas has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Dominique Lombardo
Aix Marseille Univ, INSERM, CRO2, Centre de Recherche en Oncologie biologique et Oncopharmacologie, Marseille, France
3 shared publications - Anders Molven
Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway
2 shared publications - Bente Berg Johansson
Mohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway
2 shared publications - Karianne Fjeld
Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Norway
2 shared publications Khadija El Jellas
2 shared publicationsAnny Gravdal
1 shared publication
Latest Publications
- 1 June 2018
- Published by Elsevier in Pancreatology
- Vol. 18 (4) , S34-S35
Different effects of frameshift mutations occurring in the repeat region of the pancreatic enzyme carboxyl ester lipase (CEL)
- 1 June 2018
- Published by Elsevier in Pancreatology
- Vol. 18 (4) , S34-S35
Different effects of frameshift mutations occurring in the repeat region of the pancreatic enzyme carboxyl ester lipase (CEL)
- Open Access
- 1 January 2012
- Published by Taylor & Francis in OncoImmunology
- Vol. 1 (1) , 56-61
Investigation of a new tumor-associated glycosylated antigen as target for dendritic cell vaccination in pancreatic cancer
Glycoproteins, as valuable targets for dendritic cell (DC)-vaccination in cancers, remain an open question. Glycosylated structures, which are aberrantly modified during cancerisation, impact positively or negatively on glycoprotein immunogenicity. Here is presented an oncofetal glycovariant of bile-salt-dependent-lipase, expressed on human tumoral pancreas and efficiently processed by DC’s, inducing T-lymphocyte activation.
- 1 January 2012
- Published by Taylor & Francis in OncoImmunology
- Vol. 1 (1) , 56-61
Open AccessInvestigation of a new tumor-associated glycosylated antigen as target for dendritic cell vaccination in pancreatic cancer
Glycoproteins, as valuable targets for dendritic cell (DC)-vaccination in cancers, remain an open question. Glycosylated structures, which are aberrantly modified during cancerisation, impact positively or negatively on glycoprotein immunogenicity. Here is presented an oncofetal glycovariant of bile-salt-dependent-lipase, expressed on human tumoral pancreas and efficiently processed by DC’s, inducing T-lymphocyte activation.
- Open Access
- 1 January 1997
- Published by Wiley in European Journal of Biochemistry
- Vol. 243 (1-2) , 299-305
Investigation of Two Glycosylated Forms of Bile‐Salt‐Dependent Lipase in Human Pancreatic Juice
Pure human pancreatic bile-salt-dependent lipase, devoid of its oncofetal glycoform [Mas, E., Abouakil, N., Roudani, S., Miralles, F., Guy-Crotte, O., Figarella, C., Escribano, M. J. & Lombardo, D. (1993) Biochem. J. 289, 609–6151, was analyzed on immobilized concanavalin A (ConA). Two variants were separated: an unabsorbed ConA-unreactive fraction; and an absorbed ConA-reactive fraction. Carbohydrate compositions of ConA-reactive and ConA-unreactive fractions were not significantly different, and analysis of 3H-labelled oligosaccharides liberated from these fractions on the ConA-Sepharose column indicated that the fractionation of the bile-salt-dependent lipase on this column depends upon oligosaccharide structures. The activity of the ConA-reactive fraction was however much lower, independent of the substrate (4-nitrophenyl hexanoate or cholesteryl esters), than that of the ConA-unreactive fraction. Therefore, catalytic constants for the hydrolysis of 4-nitrophenyl hexanoate were determined; both fractions had quite similar Km, while the kcat, for the ConA-unreactive fraction was 3–4-fold higher than that of the ConA-reactive fraction. ConA-reactive and ConA-unreactive fractions were shown to have slightly different molecular masses and different amino acid compositions. Cleavage patterns after cyanogen bromide treatment of the ConA-reactive and ConA-unreactive fractions suggested that the ConA-reactive (high Mr, form) and ConA-unreactive (low Mrform) forms could be different isoforms of the bile-salt-dependent lipase secreted by the human pancreas.
- 1 January 1997
- Published by Wiley in European Journal of Biochemistry
- Vol. 243 (1-2) , 299-305
Open AccessInvestigation of Two Glycosylated Forms of Bile‐Salt‐Dependent Lipase in Human Pancreatic Juice
Pure human pancreatic bile-salt-dependent lipase, devoid of its oncofetal glycoform [Mas, E., Abouakil, N., Roudani, S., Miralles, F., Guy-Crotte, O., Figarella, C., Escribano, M. J. & Lombardo, D. (1993) Biochem. J. 289, 609–6151, was analyzed on immobilized concanavalin A (ConA). Two variants were separated: an unabsorbed ConA-unreactive fraction; and an absorbed ConA-reactive fraction. Carbohydrate compositions of ConA-reactive and ConA-unreactive fractions were not significantly different, and analysis of 3H-labelled oligosaccharides liberated from these fractions on the ConA-Sepharose column indicated that the fractionation of the bile-salt-dependent lipase on this column depends upon oligosaccharide structures. The activity of the ConA-reactive fraction was however much lower, independent of the substrate (4-nitrophenyl hexanoate or cholesteryl esters), than that of the ConA-unreactive fraction. Therefore, catalytic constants for the hydrolysis of 4-nitrophenyl hexanoate were determined; both fractions had quite similar Km, while the kcat, for the ConA-unreactive fraction was 3–4-fold higher than that of the ConA-reactive fraction. ConA-reactive and ConA-unreactive fractions were shown to have slightly different molecular masses and different amino acid compositions. Cleavage patterns after cyanogen bromide treatment of the ConA-reactive and ConA-unreactive fractions suggested that the ConA-reactive (high Mr, form) and ConA-unreactive (low Mrform) forms could be different isoforms of the bile-salt-dependent lipase secreted by the human pancreas.